The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
Visits to the emergency room related to mental health among young adults, teenagers, and children spiked between 2011 and 2020, according to the Journal of the American Medical Association. The annual number rose form 4.8 million to 7.5 million over that period.
A new study suggests water on Mars may be more widespread and recent than previously thought. Scientists reported the finding from China's Mars rover in Science Advances on Friday.
Thinking about trying a new diet but not sure which way to go? An evidence-based analysis of 10 popular eating patterns shows some promote heart health much better than others.
Camilla Marcus, founder of West-Bourne, joined Cheddar News to highlight the issue of wastefulness in the food industry and spoke on the importance of regenerative farming amid a growing climate crisis.
